The treatment regimens included in our analyses were : XELOX ( oxaliplatin and capecitabine ) ; leucovorin and fluorouracil ; capecitabine ; FOLFOX-4 ( leucovorin , fluorouracil , and oxaliplatin ) ; and modified FOLFOX-6 ( mFOLFOX-6 ) .